Top1000 Scholar

Scholarly Index

Weiping Jia

NovaBay Pharmaceuticals (United States); 53,298 total citations; 1,051 total publications; best world rank #102

NovaBay Pharmaceuticals (United States)

53,298Total citations
1,051Total publications
102H-index

Published ranking records

FieldWindowWorld rankNational rankImpact score
Diabetes, Cardiovascular Risks, and LipoproteinsLifetime110US 5199.49
Liver Disease Diagnosis and TreatmentLifetime393US 14399.43
Diabetes Treatment and ManagementLifetime135US 6399.40
Diet, Metabolism, and DiseaseLifetime159US 6898.99
Metabolism, Diabetes, and CancerLifetime201US 8999.09
Diet and metabolism studiesLifetime590US 25498.94
Diabetes Management and ResearchLifetime305US 15298.82
Diabetes Management and EducationLifetime124US 6898.47
Fibroblast Growth Factor ResearchLifetime102US 5497.84
Pancreatic function and diabetesLifetime480US 21498.60
Cardiovascular Disease and AdiposityLifetime269US 14098.54
Diabetes and associated disordersLifetime369US 15598.39
Lipid metabolism and disordersLifetime175US 7497.85
Adipose Tissue and MetabolismLifetime894US 39297.97
Adipokines, Inflammation, and Metabolic DiseasesLifetime463US 20098.02
Metabolomics and Mass Spectrometry StudiesLifetime597US 23897.20
Kruppel-like factors researchLifetime153US 5996.67
Peroxisome Proliferator-Activated ReceptorsLifetime475US 23196.89
Traditional Chinese Medicine StudiesLifetime324US 1693.33
Chronic Kidney Disease and DiabetesLifetime623US 25896.68
Bariatric Surgery and OutcomesLifetime503US 22195.68
Chronic Disease Management StrategiesLifetime958US 30694.98
Hyperglycemia and glycemic control in critically ill and hospitalized patientsLifetime935US 40190.99
Cardiovascular Health and Risk FactorsLifetime914US 45789.98
Gout, Hyperuricemia, Uric AcidLifetime713US 21289.33
Artificial Intelligence in HealthcareLifetime860US 11586.95
Liver Disease Diagnosis and Treatment2021-2025238US 6498.72
Diet and metabolism studies2021-2025384US 11796.17
Metabolomics and Mass Spectrometry Studies2021-2025317US 7693.17
Diabetes, Cardiovascular Risks, and Lipoproteins2021-2025236US 6494.20
Diabetes Treatment and Management2021-2025436US 15595.37
Metabolism, Diabetes, and Cancer2021-2025269US 7191.99
Diabetes Management and Research2021-2025894US 31390.53
Artificial Intelligence in Healthcare2021-2025403US 3386.94
Diet, Metabolism, and Disease2021-2025562US 10587.13
Fibroblast Growth Factor Research2021-2025143US 5385.22
Peroxisome Proliferator-Activated Receptors2021-2025196US 3681.09
Machine Learning in Healthcare2021-2025499US 19583.32
Adipokines, Inflammation, and Metabolic Diseases2021-2025979US 19675.09
Kruppel-like factors research2021-2025471US 10463.60